Drug Profile
BR 05001
Alternative Names: BR-05001Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Boryung Pharmaceutical
- Class Cytokines
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaemia
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Anaemia in South Korea (Controlled release)
- 08 Jul 2016 Preclinical trials in Anaemia in South Korea (unspecified route)